SCHEDULE: Greenleaf Trust Reduces Stryker Stake Below 5%

Greenleaf Trust has filed an amendment to its Schedule 13G, reporting a decrease in its beneficial ownership of Stryker Corporation's common stock to 4.4%.

Summary

• Greenleaf Trust, a bank based in Michigan, filed an Amendment No. 19 to its Schedule 13G for Stryker Corporation (NYSE: SYK).
• The filing indicates that as of December 31, 2025, Greenleaf Trust beneficially owned 16,801,654 shares of Stryker's common stock.
• This aggregate amount represents 4.4% of Stryker Corporation's outstanding common stock.
• Greenleaf Trust holds these securities in a fiduciary capacity on behalf of various trust and investment management customers.
• The filing explicitly states that Greenleaf Trust has ceased to be the beneficial owner of more than five percent of the class of securities.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as slightly negative due to a significant institutional investor reducing its stake below the 5% threshold, which can sometimes signal a lack of conviction or portfolio rebalancing, potentially impacting market sentiment.

Negatives

• The reduction in Greenleaf Trust's beneficial ownership to below 5% could be perceived by the market as a negative signal, potentially indicating a shift in investment strategy or outlook by a significant institutional holder.

Risks

• Potential negative market perception due to a significant institutional investor reducing its stake below the 5% threshold, which could lead to short-term stock price volatility.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that institutional ownership changes, especially reductions below key thresholds like 5%, are closely watched by the market as they can signal shifts in investor sentiment or portfolio rebalancing strategies within the medical technology sector. While this filing indicates a reduction, it does not provide specific reasons for Greenleaf Trust's decision.

Stakeholder Impact

• Shareholders may interpret the reduction in institutional ownership as a signal, potentially influencing their investment decisions or contributing to short-term stock price fluctuations.

Key Dates

Recommendation

The reduction in Greenleaf Trust's stake below 5% is a notable institutional ownership change. While it could reflect routine portfolio rebalancing rather than a fundamental negative view on Stryker's operations, investors should monitor for further institutional activity or company-specific news. Without additional context, a 'hold' recommendation is appropriate, advising investors to maintain their current positions while observing market reactions and future developments.

Keywords

Stryker Corporation, Greenleaf Trust, Schedule 13G/A, Beneficial Ownership, Institutional Investor, Medical Technology, SYK